These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24289048)

  • 1. Why the results of the American College of Surgeons Oncology Group Z0011 Trial are so important.
    Spillane A
    ANZ J Surg; 2013 Dec; 83(12):893. PubMed ID: 24289048
    [No Abstract]   [Full Text] [Related]  

  • 2. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
    Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
    Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer.
    Yao K; Liederbach E; Pesce C; Wang CH; Winchester DJ
    J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
    White RL; Wilke LG
    Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early adoption and disturbing disparities in sentinel node biopsy in breast cancer.
    Edge SB
    J Natl Cancer Inst; 2008 Apr; 100(7):449-50. PubMed ID: 18364503
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system.
    Wright GP; Mater ME; Sobel HL; Knoll GM; Oostendorp LD; Melnik MK; Chung MH
    Am J Surg; 2015 Feb; 209(2):240-5. PubMed ID: 25236187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Importance of Applying ACOSOG Z0011 Criteria in the Axillary Management of Invasive Lobular Carcinoma: A Multi-institutional Cohort Study.
    Roberts A; Nofech-Mozes S; Youngson B; McCready DR; Al-Assi M; Ramkumar S; Cil T
    Ann Surg Oncol; 2015 Oct; 22(10):3397-401. PubMed ID: 26215196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Size of Extranodal Extension on Sentinel Lymph Node Dissection in the American College of Surgeons Oncology Group Z0011 Trial Era.
    Choi AH; Blount S; Perez MN; Chavez de Paz CE; Rodriguez SA; Surrusco M; Garberoglio CA; Lum SS; Senthil M
    JAMA Surg; 2015 Dec; 150(12):1141-8. PubMed ID: 26331347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary surgery: clinical judgment required.
    Henderson IC
    J Clin Oncol; 2006 Jan; 24(3):325-6. PubMed ID: 16344313
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
    Ainsworth RK; Kollias J; Le Blanc A; De Silva P
    Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Paradigm Shift in Axillary Breast Cancer Treatment; From "Treat All-Except," Toward "Treat None-Unless".
    van den Hoven I; Voogd AC; Roumen RM
    Clin Breast Cancer; 2015 Dec; 15(6):399-402. PubMed ID: 26253641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.
    Ngui NK; Elder EE; Jayasinghe UW; French J
    ANZ J Surg; 2013 Dec; 83(12):924-8. PubMed ID: 24289051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Z-11 trial and rethinking axillary reverse mapping.
    Noguchi M
    Breast Cancer; 2015 Mar; 22(2):99-100. PubMed ID: 25577513
    [No Abstract]   [Full Text] [Related]  

  • 14. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
    Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
    Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel node dissection in early-stage breast cancer: ongoing prospective randomized trials in the USA.
    Ross MI
    Ann Surg Oncol; 2001 Oct; 8(9 Suppl):77S-81S. PubMed ID: 11599908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is SLN Biopsy Alone Safe in SLN Positive Breast Cancer Patients?
    van la Parra RF; de Wilt JH; Mol SJ; Mulder AH; de Roos WK; Bosscha K
    Breast J; 2015; 21(6):621-6. PubMed ID: 26391102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is axillary dissection unnecessary in patients with a positive sentinel lymph node?
    Noguchi M
    Breast Cancer; 2012 Oct; 19(4):279-81. PubMed ID: 22528803
    [No Abstract]   [Full Text] [Related]  

  • 18. To do or not to do: axillary nodal evaluation after ACOSOG Z0011 Trial.
    Humphrey KL; Saksena MA; Freer PE; Smith BL; Rafferty EA
    Radiographics; 2014; 34(7):1807-16. PubMed ID: 25384280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.